pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release
Authors:
- Gjylije HotiGHGjylije Hoti
- Sara Er-RahmaniSESara Er-Rahmani
- Alessia GattiAGAlessia Gatti
- Ibrahim HusseinIHIbrahim Hussein
- Monica ArgenzianoMonica Argenziano
- Roberta CavalliRCRoberta Cavalli
- Anastasia AnceschiAAAnastasia Anceschi
- Adrián MatencioAdrián Matencio
- Francesco TrottaFrancesco Trotta
- Fabrizio CalderaFabrizio Caldera
Open Access
Abstract
Dextrin-based nanosponges (D-NS) are promising candidates for oral drug delivery due to their biocompatibility, mucoadhesive properties, and tunable swelling behavior. In this study, pH-sensitive nanosponges were synthesized using β-cyclodextrin (β-CD), GluciDex®2 (GLU2), and KLEPTOSE® Linecaps (LC) as building blocks, crosslinked with pyromellitic dianhydride (PMDA) and citric acid (CA). The nanosponges were mechanically size-reduced via homogenization and ball milling, and characterized by FTIR, TGA, dynamic light scattering (DLS), and zeta potential measurements. Swelling kinetics, cross-linking density (determined using Flory–Rehner theory), rheological behavior, and mucoadhesion were evaluated under simulated gastric and intestinal conditions. The β-CD:PMDA 1:4 NS was selected for drug studies due to its optimal balance of structural stability, swelling capacity (~863% at pH 6.8), and highest apomorphine (APO) loading (8.23%) with 90.58% encapsulation efficiency. All nanosuspensions showed favorable polydispersity index values (0.11–0.30), homogeneous size distribution, and stable zeta potentials, confirming suspension stability. Storage at 4 °C for six months revealed no changes in physicochemical properties or apomorphine (APO) degradation, indicating protection by the nanosponge matrix. D-NS exhibited tunable swelling, pH-responsive behavior, and mucoadhesive properties, with nanoparticle–mucin interactions quantified by the rheological synergism parameter (∆G′ = 53.45, ∆G″ = −36.26 at pH 6.8). In vitro release studies demonstrated slow, sustained release of APO from D-NS in simulated intestinal fluid compared to free drug diffusion, highlighting the potential of D-NS as pH-responsive, mucoadhesive carriers with controlled drug release and defined nanoparticle–mucin interactions.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A ReviewMolecular Neurobiology, 2025
- Advances in the transport of oral nanoparticles in gastrointestinal tractColloids and Surfaces B: Biointerfaces, 2024
- Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevanceAgeing Research Reviews, 2024
- Food-associated stimuli enhance barrier properties of gastrointestinal mucusBiomaterials, 2015
- Acute and Repeated Dose Toxicity Studies of Different β-Cyclodextrin-Based Nanosponge FormulationsJournal of Pharmaceutical Sciences, 2015
- Role of Apomorphine in the Treatment of Parkinson’s DiseaseCNS Drugs, 2015
- Synthesis, swelling and responsive properties of a new composite hydrogel based on hydroxyethyl cellulose and medicinal stoneComposites Part B: Engineering, 2011
- Cyclodextrin Nanosponges and their Applications2011
- Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral EvaluationsJournal of Pharmaceutical Sciences, 2011
- Rheological synergy in aqueous mixtures of pectin and mucinCarbohydrate Polymers, 2008